TaiMed Biologics Inc. (TPEX: 4147)
Taiwan
· Delayed Price · Currency is TWD 78.60
-0.10 (-0.13%)
Nov 19, 2024, 1:30 PM CST
TaiMed Biologics Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1,021 | 251.01 | 274.11 | 551.62 | 572.09 | 352.93 | Upgrade
|
| Short-Term Investments | 1,155 | 395.49 | 309.93 | 406.68 | 629 | 919 | Upgrade
|
| Trading Asset Securities | - | - | 58.75 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 2,175 | 646.5 | 642.79 | 958.3 | 1,201 | 1,272 | Upgrade
|
| Cash Growth | 237.62% | 0.58% | -32.92% | -20.21% | -5.57% | -36.70% | Upgrade
|
| Accounts Receivable | 133.46 | 160.49 | 98.24 | 157.78 | 268.92 | 210.09 | Upgrade
|
| Other Receivables | 5 | 28.16 | 25.49 | 35.41 | 19.69 | 20.81 | Upgrade
|
| Receivables | 138.45 | 188.65 | 123.73 | 193.19 | 288.61 | 230.9 | Upgrade
|
| Inventory | 1,129 | 1,271 | 1,389 | 1,177 | 1,281 | 876.04 | Upgrade
|
| Prepaid Expenses | - | 10.01 | 4.15 | 3.54 | 4.73 | 5.48 | Upgrade
|
| Other Current Assets | 647.82 | 35.63 | 5.08 | 2.59 | 2.93 | 72.82 | Upgrade
|
| Total Current Assets | 4,091 | 2,151 | 2,165 | 2,335 | 2,778 | 2,457 | Upgrade
|
| Property, Plant & Equipment | 871.25 | 908.26 | 957.74 | 1,011 | 1,065 | 940.32 | Upgrade
|
| Long-Term Investments | 0.9 | 0.9 | 43.44 | 232.63 | 203 | 249.36 | Upgrade
|
| Other Intangible Assets | 563.37 | 625.79 | 724.38 | 821.33 | 940.16 | 739.45 | Upgrade
|
| Other Long-Term Assets | 207.96 | 207.58 | 210.57 | 211.19 | 210.59 | 344.47 | Upgrade
|
| Total Assets | 5,734 | 3,894 | 4,101 | 4,611 | 5,196 | 4,731 | Upgrade
|
| Accounts Payable | 564.88 | 13.5 | 0.09 | 122.58 | 6.16 | 136.17 | Upgrade
|
| Accrued Expenses | - | 7.49 | 39.39 | 51.64 | 361.04 | 227.18 | Upgrade
|
| Short-Term Debt | - | 200 | 200 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 27.11 | 26.97 | 14.32 | - | - | - | Upgrade
|
| Current Portion of Leases | 2.26 | 2.18 | 2.02 | 1.95 | 1.93 | 1.85 | Upgrade
|
| Current Unearned Revenue | 84.1 | 91.12 | 57.48 | 24.34 | 37.59 | 21.92 | Upgrade
|
| Other Current Liabilities | 44.05 | 19.92 | 16.57 | 24.57 | 54.81 | 40.99 | Upgrade
|
| Total Current Liabilities | 722.39 | 361.17 | 329.86 | 225.08 | 461.52 | 428.11 | Upgrade
|
| Long-Term Debt | 474.88 | 495.04 | 521.68 | 536 | 536 | - | Upgrade
|
| Long-Term Leases | 25.66 | 26.67 | 28.12 | 29.38 | 31.32 | 32.15 | Upgrade
|
| Long-Term Unearned Revenue | 362.92 | 444.04 | 505.6 | 877.9 | 750.74 | 683.25 | Upgrade
|
| Other Long-Term Liabilities | 0.92 | 0.92 | 0.92 | 0.87 | 0.86 | 0.86 | Upgrade
|
| Total Liabilities | 1,587 | 1,328 | 1,386 | 1,669 | 1,780 | 1,144 | Upgrade
|
| Common Stock | 2,731 | 2,530 | 2,526 | 2,523 | 2,522 | 2,522 | Upgrade
|
| Additional Paid-In Capital | - | 986.67 | 945.45 | 925.14 | 4,832 | 4,814 | Upgrade
|
| Retained Earnings | -1,016 | -934.56 | -740.22 | -470.93 | -3,921 | -3,737 | Upgrade
|
| Comprehensive Income & Other | 2,432 | -16.13 | -15.83 | -35.97 | -17.6 | -11.76 | Upgrade
|
| Shareholders' Equity | 4,147 | 2,566 | 2,715 | 2,942 | 3,416 | 3,586 | Upgrade
|
| Total Liabilities & Equity | 5,734 | 3,894 | 4,101 | 4,611 | 5,196 | 4,731 | Upgrade
|
| Total Debt | 529.91 | 750.86 | 766.14 | 567.32 | 569.25 | 34 | Upgrade
|
| Net Cash (Debt) | 1,646 | -104.35 | -123.35 | 390.98 | 631.84 | 1,238 | Upgrade
|
| Net Cash Growth | - | - | - | -38.12% | -48.96% | -38.40% | Upgrade
|
| Net Cash Per Share | 6.35 | -0.41 | -0.49 | 1.55 | 2.51 | 4.91 | Upgrade
|
| Filing Date Shares Outstanding | 269.91 | 253.01 | 252.55 | 252.33 | 252.22 | 252.19 | Upgrade
|
| Total Common Shares Outstanding | 269.91 | 253.01 | 252.55 | 252.33 | 252.22 | 252.19 | Upgrade
|
| Working Capital | 3,368 | 1,790 | 1,835 | 2,110 | 2,316 | 2,029 | Upgrade
|
| Book Value Per Share | 15.37 | 10.14 | 10.75 | 11.66 | 13.54 | 14.22 | Upgrade
|
| Tangible Book Value | 3,584 | 1,940 | 1,991 | 2,120 | 2,476 | 2,847 | Upgrade
|
| Tangible Book Value Per Share | 13.28 | 7.67 | 7.88 | 8.40 | 9.82 | 11.29 | Upgrade
|
| Land | - | 194.61 | 194.61 | 194.61 | 194.61 | 194.61 | Upgrade
|
| Buildings | - | 493.95 | 493.54 | 493.12 | 492.72 | 359.17 | Upgrade
|
| Machinery | - | 455.56 | 450.03 | 446.9 | 443.66 | 272.62 | Upgrade
|
| Construction In Progress | - | - | - | - | - | 137.56 | Upgrade
|
| Leasehold Improvements | - | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.